Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease

Table 2 Comparison of serum betatrophin, angiopoietin-like protein 3 and lipoprotein lipase levels in coronary heart disease group and control group

Variables	Kazakh			Han
	CHD (n = 79)	Non-CHD (n = 72)	P value	CHD (n = 61)	Non-CHD (n = 65)	P value
Betatrophin (pg/mL)	435.32 ± 60.361,2	243.21 ± 62.731	< 0.001	408.26 ± 57.452	219.73 ± 59.37	0.031
ANGPTL3 (ng/mL)	3.42 ± 1.631,2	2.69 ± 1.331	0.022	3.27 ± 1.452	2.52 ± 1.53	0.038
LPL (ng/mL)	56.37 ± 13.271,2	42.37 ± 13.161	0.043	54.52 ± 14.522	41.42 ± 12.26	0.021

¹Compared with control group (P < 0.05).

²P: Compared with Han CHD group (P < 0.05).

CHD: Coronary heart disease; SBP: Systolic blood pressure; ANGPTL3: Angiopoietin-like protein 3; LPL: Lipoprotein lipase.